jamiebell

320 POSTS 0 COMMENTS

ESOC 2022: New study links gut microbiota strains with more severe...

A new study has identified strains of gut microbiota that are associated with more severe strokes and worse post-stroke recovery, revealing that the gut...

FDA approves launch of “largest clinical trial to date” for tDCS...

Flow Neuroscience, which claims to be the creator of Europe’s first medically approved brain stimulation device to treat depression at home, has received full...

Medtronic announces first implant in study evaluating investigational, closed-loop neurostimulator

Medtronic today announced the first patient implant in a clinical study of its investigative, closed-loop, implantable neurostimulator. The ‘Evaluation of long-term patient experience with...

Stroke in young people may be associated with increased likelihood of...

The risk of being diagnosed with a new cancer in the follow-up of patients with a first-ever stroke is particularly increased in patients younger...

First commercial Vivistim patient set to begin paired vagus nerve stimulation...

MicroTransponder recently announced the first commercial use of its Vivistim paired vagus nerve stimulation (VNS) system for improved upper-limb function post-stroke. The company said...

Vesalio announces completion of enrolment in acute ischaemic stroke IDE study

vesalio
Vesalio has announced the completion of patient enrolment for the CLEAR US Food and Drug Administration (FDA) investigational device exemption (IDE) study utilising the NeVa...

STAR network and Avail Medsystems partner to aid remote physician collaboration

Avail Medsystems has announced that it has entered into a partnership with the Stroke Thrombectomy and Aneurysm Registry (STAR), led by Alejandro Spiotta (Medical...

Dolphin vagal nerve stimulator gains Health Canada nod for ‘long-haul’ COVID-19...

Health Canada recently authorised the Dolphin vagal nerve stimulator to treat symptoms in patients with COVID-19 ‘long-haul’ symptoms (long haulers). Long haulers experience a wide variety of aftereffects...

NeuroNews’ top 10 most popular stories of April 2022

Novel neurovascular technologies, from robotics, to microcatheters, to artificial intelligence (AI), were among the hottest topics featured on NeuroNews in April. A momentous company...

Synchron enrols first patient in US COMMAND study of endovascular brain-computer...

Synchron has announced enrolment of the first patient in the US COMMAND clinical trial for patients with severe paralysis at Mount Sinai Hospital in...

ATTENTION results indicate “we have finally conquered the basilar artery” with...

attention evt basilar
This year’s European Stroke Organisation Conference (ESOC 2022; 4–6 May, Lyon, France) saw results from ATTENTION—a multicentre randomised controlled trial (RCT) evaluating the benefit...

Artificial intelligence tutoring outperforms expert instructors in neurosurgical training

Against the backdrop of remote learning technologies becoming increasingly important within medical training during the COVID-19 pandemic, a new study has found that—in a...

Carotid stenosis in women: Should the approach differ?

carotid stenosis women
The existing evidence on whether women with carotid stenosis experience inferior treatment outcomes compared to men is mixed—and this uncertainty is reflected in the...

NeuroPace announces first treatment in pivotal study evaluating RNS system in...

NeuroPace has announced that the first patient was recently treated in the RESPONSE clinical trial, which is evaluating the safety and effectiveness of the...

ESOC 2022: ‘Brain-age’ biomarkers predict stroke recovery more accurately than chronological...

Stroke experts have identified how radiomics—an emerging, image-quantifying technology—can be used to extract biomarkers from clinical brain magnetic resonance imaging (MRI) scans in stroke...

Study findings encourage direct EVT approaches over bridging thrombolysis in select...

A retrospective study involving more than 200 patients has indicated that ‘bridging thrombolysis’ may not be associated with improved functional outcomes in stroke patients...

Millimetric implant offers promising alternative to opioids or surgery in pain...

Using a one-millimetre-sized wireless implant to stimulate peripheral nerves from within blood vessels has the potential to treat neuropathic pain that is resistant to...

“Largest ever” study on traumatic brain injury highlights global inequality in...

traumatic brain injury
Neurosurgery experts from the University of Cambridge (Cambridge, UK) have led what is claimed to be the largest ever study examining the surgical management...

Recommended use of SCS in neuropathic pain has not led to...

Only a small proportion of neuropathic pain patients in England who are potentially eligible for spinal cord stimulation (SCS) have received this intervention over...

Avicenna.AI signs distribution agreement with Sectra for neurovascular AI solutions

Avicenna.AI has announced a signed distribution agreement with Sectra—an international medical imaging information technology (IT) and cybersecurity company. The agreement will see Avicenna’s AI...

Baptist Health South Florida to acquire ZAP-X gyroscopic radiosurgery platform

ZAP Surgical Systems announced today that Baptist Health South Florida (Miami, USA) will acquire the ZAP-X gyroscopic radiosurgery platform for cranial stereotactic radiosurgery (SRS)....

First patient treated in clinical trial of CereVasc’s eShunt system for...

CereVasc has announced treatment of the first patient in its clinical study of the eShunt system in patients with normal-pressure hydrocephalus (NPH). Following approval from Argentina's...

MIT engineers develop joystick-operated robot to help surgeons treat stroke remotely

Engineers from the Massachusetts Institute of Technology (MIT) in Cambridge, USA have developed a telerobotic system to enable surgeons to quickly and remotely treat...

GT Medical Technologies to present clinical data on GammaTile brain tumour...

GT Medical Technologies announced today that new data on the company's innovative GammaTile therapy for patients with operable brain tumours will be presented via...

Medtronic names Laura Mauri as new chief scientific, medical and regulatory...

Medtronic has announced that Laura Mauri has been appointed as the company’s chief scientific, medical and regulatory officer. This appointment adds to Mauri's prior responsibilities...

Abbott upgrades NeuroSphere myPath app for patient monitoring in neuromodulation trials

Abbott today announced that it has launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality intended to help doctors...

International Neuromodulation Society announces “Innovations in Neuromodulation” event at May congress

With an educational event entitled “Innovations in Neuromodulation”, the International Neuromodulation Society (INS) will attempt to bring together industry leaders, innovators and investors to...

Microvention announces enrolment of first patient in STRAIT study evaluating new...

Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the successful completion of its first patient enrolment in a multicentre, prospective, observational study...

Stimwave launches FREEDOM series with trial evaluating PNS in chronic knee...

Stimwave Technologies has announced the launch of its level-one FREEDOM clinical trial series—which consists of multicentre, prospective, randomised trials that monitor chronic pain patients’...

Wallaby acquires phenox to accelerate global expansion in neurovascular space

Wallaby Medical today announced that it has acquired phenox GmbH—including phenox's femtos GmbH—for a total consideration of approximately €500 million including milestone payments. The acquisition is...

Women less likely to return to work after severe stroke, new...

According to new research published in Stroke, about one third of people who had a severe ischaemic stroke—and underwent a mechanical thrombectomy to remove...

UK stroke patients among thousands left waiting more than one hour...

In March 2022, more than 390,000 people who called 999 with emergencies including suspected stroke waited for an average of over one hour for...

NeuraLace announces two new patents for Axon neuropathic pain therapies

NeuraLace Medical has announced the expansion of its global patent portfolio with the issuance of two new patents: US Patent No. 11,305,130 for "Devices, systems,...

Axonics announces comprehensive launch of F15 recharge-free SNM system

Axonics today announced the comprehensive launch of the Axonics F15 across the USA. The newly developed, long-lived, fully recharge-free sacral neuromodulation (SNM) system also...

Bendit receives FDA 510(k) clearance for 0.021-inch steerable microcatheter

Bendit Technologies has received US Food and Drug Administration (FDA) 510(k) clearance of its Bendit21 microcatheter for treatment in the neuro, peripheral and coronary...

Preliminary data indicate improved neurological outcomes with alteplase versus placebo

As per early findings from the CHOICE randomised controlled trial (RCT), the use of adjunct, intra-arterial alteplase—among patients with large vessel occlusion (LVO) acute...

Corindus relocates Massachusetts headquarters to accommodate company growth

Corindus, a Siemens Healthineers company, announced today the opening of its new headquarters at 275 Grove Street in Newton, USA. Siemens Healthineers relocated the...

CX 2022: Acute stroke programme seeks to evaluate study data and...

Barbara Rantner (Munich, Germany) previews the Acute Stroke Challenges programme at CX 2022—a two-hour session featuring several debates and audience polls on carotid disease...

Viz.ai raises US$100 million in Series D funding to expand AI...

viz series d
Viz.ai has raised a US$100 million funding round at a US$1.2 billion valuation, as per a company press release. The Series D round, which...

Michael Chen

michael chen
Michael Chen—a neurointerventionist and professor of Neurology, Neurosurgery and Radiology at Rush University Medical Center in Chicago, USA—speaks to NeuroNews to provide insight on...

Guidewire-less neurovascular navigation system shows promise in rabbit aneurysm model

A new concept for navigating the neurovasculature, performed without the aid of a guidewire, has demonstrated its ability to be manoeuvred through tortuous vessels,...

Aidoc gains FDA 510(k) clearance for AI-supported triage and notification of...

Aidoc has received US Food and Drug Administration (FDA) 510(k) clearance for the triage and notification of brain aneurysm—which affects one in 50 people...

NeuroNews’ top 10 most popular stories of March 2022

Industry-fronting experts from the worlds of neurointerventional surgery and neuromodulation alike weighed in on a number of key topics throughout the month of March....

Cefaly publishes study data indicating effectiveness of e-TNS migraine treatment

Cefaly Technology has announced the results of a clinical study demonstrating that two-hour treatment with its external trigeminal nerve stimulation (e-TNS) Cefaly device is...

Study data indicate positive outcomes with “exciting new treatment option” in...

Data from a multicentre clinical study supporting the use of Anaconda Biomed’s Advanced Neurovascular Access (ANA) catheter system for treating ischaemic stroke have been...

London clinic becomes first in UK to offer new drug-free Alzheimer’s...

The London Alzheimer’s Clinic on Harley Street (London, UK) has become the first clinic in the UK to offer transcranial pulse stimulation (TPS)—a “revolutionary”...

Why robotics holds the key to the future of stroke treatment

robotics stroke treatment
Vitor Pereira and Nicole Cancelliere (St Michael’s Hospital, Toronto, Canada) outline recent breakthroughs in the deployment of robotics for neurointerventional procedures and discuss future...

Radial access is not just a new toy—it has come to...

This advertorial is sponsored by Medtronic. Upon gaining CE-mark approval in September of last year, the Rist radial access system (Medtronic) became the first dedicated...

Biomodex launches clear cartridges for neurovascular surgery training

Biomodex has announced the launch of new clear cartridges for use with all of its EVIAS (Endovascular intracranial aneurysm system) and EVIAS Plus stations for preprocedural...

NeuroNews issue 45 – US

Highlights:  Japanese study—first presented at the International Stroke Conference (ISC)—sheds light on mechanical thrombectomy in severe ischaemic stroke patients The pros and cons of...

NeuroNews issue 45 – EU

Highlights:  Japanese study—first presented at the International Stroke Conference (ISC)—sheds light on mechanical thrombectomy in severe ischaemic stroke patients The pros and cons of...

Implantable brain-computer interface enables completely locked-in patient to communicate

Researchers at the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), in collaboration with the University of Tübingen (Tübingen, Germany), have enabled a person...

Synchron announces long-term safety results with Stentrode device for severe paralysis

synchron stentrode safety
Synchron has announced the results from a study in which four people with amyotrophic lateral sclerosis (ALS) received an implant of the company’s Stentrode...

Sonocloud technology demonstrates safety and therapeutic potential in Alzheimer’s patients

sonocloud alzheimer's
Carthera has announced today the publication of results from an investigator-sponsored pilot clinical trial evaluating safety and efficacy using its Sonocloud technology in patients...

Cerus Endovascular receives FDA clearance for 027 microcatheter products

Cerus Endovascular has received US Food and Drug Administration (FDA) 510(k) clearance for its 027 microcatheters, available in two lengths, expanding on a product...

Survey uncovers “far-reaching” impact of pandemic on patients with chronic back...

A new survey commissioned by Medtronic and conducted by public opinion research firm The Harris Poll has found that 44% of current chronic back...

Medtronic announces first patient implants of investigational TNM therapy for bladder...

Medtronic recently announced the first patients have been implanted in the TITAN 2 pivotal study—which will evaluate the safety and efficacy of its investigational...

High-frequency SCS drives impactful outcomes for non-surgical refractory back pain patients

senza-nsrbp
Following the recent introduction of key data supporting the use of high-frequency spinal cord stimulation (SCS) in the treatment of non-surgical refractory back pain...

AAN issues new guidance on preventing second stroke in patients with...

In patients with intracranial atherosclerosis, the use of medications and exercise is more beneficial in preventing a second stroke than placing a stent in...

Stimwave Technologies provides update on reimbursement of chronic pain therapies

Stimwave Technologies has provided an update on recent reimbursement-related progress pertaining to its chronic pain therapies—which include implantable spinal cord stimulation (SCS) and peripheral...

AiM Medical Robotics raises US$3.4 million to accelerate MRI-compatible robotics platform

AiM Medical Robotics recently announced that it has raised US$3.4 million in seed funding, led by IQ Capital and Surrey Capital Partners. Other investors include The...

Zeta Surgical secures US$5.2 million to enhance AI-driven neurosurgical technologies

Zeta Surgical has announced the close of US$5.2 million in seed financing—and will use these funds to finalise development of its neurosurgical navigation platform, Zeta,...

Pushing the boundaries of aneurysm detection, monitoring and care with AI

ai cerebral aneurysm
Alejandro Spiotta (Medical University of South Carolina, Charleston, USA) outlines what he believes could be the next frontier in cerebral aneurysm care—artificial intelligence (AI)—and...

Lower frequencies may improve outcomes of pain treatment with dorsal root...

Lower frequencies of dorsal root ganglion stimulation (DRG-S) may be more effective in the treatment of neuropathic pain—as per a late-breaking presentation from Guilherme...

The pros and cons of radial access in neurointerventional surgery

radial access neurointerventional surgery
As the adoption of radial access across the world of neurointerventional surgery begins to pick up pace, Pascal Jabbour and Kareem El Naamani (Thomas...

Remote blood pressure monitoring beneficial for stroke survivors in under-resourced areas

A new strategy using telehealth to monitor blood pressure at home for several months immediately after a stroke had a positive impact on patient engagement and blood...

Multiple daily doses of iTBS provide no additional benefit in treatment-resistant...

cartbind study
In patients with treatment-resistant depression (TRD), multiple sessions of intermittent theta-burst stimulation (iTBS) do not accelerate responses to the therapy, nor do they improve...

PathMaker initiates US multicentre trial evaluating non-invasive post-stroke spasticity treatment

PathMaker Neurosystems has announced initiation of its US multicentre clinical trial to evaluate MyoRegulator for the non-invasive treatment of post-stroke upper-limb spasticity. The trial is...

New technology enables option for neurosurgeons to avoid pinning patients’ heads...

Following the introduction of its BrainPath navigation probe adapter at the International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA), medical device innovator NICO Corporation claims...

Axonics receives FDA approval for new recharge-free sacral neuromodulation system

Axonics has announced that the US Food and Drug Administration (FDA) has approved its newly developed, long-lived, recharge-free sacral neuromodulation (SNM) implantable neurostimulator, the...

Rapid Medical announces Eitan Havis as international president

Rapid Medical has announced the promotion of Eitan Havis to international president of the company. Havis will oversee the commercial expansion of the company’s advanced neurovascular...

Valencia Technologies announces FDA approval of eCoin therapy for urinary urge...

Valencia Technologies Corporation has announced that the US Food and Drug Administration (FDA) has granted premarket approval of its eCoin leadless tibial neurostimulator for...

AI, cost reductions and more represent bright future for neuromodulation industry

On technological and commercial fronts alike, the neuromodulation space is one of the more rapidly evolving subsectors within the medical industry—and has undergone a...

Registration opens for 15th International Neuromodulation Society congress in Barcelona

At the International Neuromodulation Society (INS) 15th world congress (21–26 May 2022; Barcelona, Spain), researchers from over 40 countries will present plenary lectures and...

Multiple-modality spinal cord stimulation demonstrates sustained improvement in chronic pain outcomes

A spinal cord stimulation (SCS) system capable of simultaneously delivering multiple treatment modalities has produced a sustained improvement in outcomes in a randomised controlled...

NeuroNews’ top 10 most popular stories of February 2022

Highlights from the International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA)—predominantly relating to mechanical thrombectomy studies—grabbed our readers’ attention throughout February. New...

NeuroOne releases successful completion of long-term stimulation tests with novel, thin-film...

NeuroOne Medical Technologies has announced that it successfully completed initial, bench-top, long-term stimulation testing on a novel design of its thin-film electrode technology. The...

First patient implanted in clinical study assessing hypoglossal nerve stimulation for...

LivaNova has announced the first patient has been implanted as part of an investigational device exemption (IDE) clinical study, dubbed OSPREY (Treating obstructive sleep apnea using...

Accuray announces NICE endorsement for radiosurgery treatment of trigeminal neuralgia

Accuray has announced that the National Institute for Health and Care Excellence (NICE) has endorsed the use of its radiosurgery technology for trigeminal neuralgia—strengthening...

Microvention announces treatment of first US patient with FRED X flow...

Microvention, a subsidiary of Terumo, has announced the first US clinical case using its next-generation flow diverter, the FRED X device, at Thomas Jefferson University Hospital...

Viz.ai receives FDA 510(k) clearance for cerebral aneurysm detection algorithm

viz series d
Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for Viz ANEURYSM—a new algorithm that uses artificial intelligence (AI) to detect suspected...

Lack of evidence among challenges that must be overcome to realise...

In spite of the clinical successes observed to date, a lack of high-level safety and efficacy evidence, among other current challenges and limitations, must...

FDA grants Aleva Neurotherapeutics approval for IDE study with directSTIM system

Aleva Neurotherapeutics has received a letter of approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) study assessing...

Medtronic receives FDA approval for InterStim X system for bladder and...

Medtronic has announced receipt of approval from the US Food and Drug Administration (FDA) for its new, recharge-free InterStim system—with the device being made...

Children with severe stroke may fare better if treatment includes mechanical...

Serious disability is six times more likely to be the result three months after stroke among children whose large-vessel stroke was not treated with...

Neuromod welcomes study demonstrating safety and efficacy of Lenire device in...

Neuromod Devices has welcomed the findings of an independent study performed at the German Hearing Center at Hannover Medical School (Hannover, Germany), which found...

ISC 2022: New study finds better outcomes in patients treated at...

When comparing outcomes for acute ischaemic stroke patients treated at various levels of stroke centres, patients who received care at comprehensive stroke centres (CSC) or thrombectomy-capable...

Single-patient study offers promise for individualised depression treatment with DBS

Despite its small sample size, a study in which a patient received closed-loop, deep brain stimulation (DBS) therapy has demonstrated positive clinical outcomes and...

Myopro shows clinically significant gains in motor function for chronic moderate-to-severe...

Myomo has announced that new research measuring the benefits of its Myopro myoelectric orthosis found “statistically significant improvements” in a number of motor function...

New player in stent retriever space demonstrates non-inferiority to Solitaire device

A relatively new introduction to the field of endovascular therapy (EVT) for acute ischaemic stroke, the Skyflow stent retriever (Skyflow), has demonstrated non-inferiority with...

Study shows positive impact of new in-app feature on Nerivio REN...

A new peer-reviewed study published in Pain Medicine, examining the use of Nerivio’s (Theranica) guided imagery, education and relaxation (GIER) in-app optional behavioural intervention...

Newer clot-busting medication may someday increase time window for stroke treatment

In a phase 2a clinical trial in China, the clot-busting medication tenecteplase has been shown to be effective in restoring blood flow to the...

Rapid Medical receives FDA Breakthrough Device designation for vasospasm treatment

Rapid Medical has announced US Food and Drug Administration (FDA) Breakthrough Device designation for its Comaneci embolisation assist technology, which is intended to facilitate the treatment of...

Imperative launches Zoom POD aspiration tubing for use in stroke treatments

imperative zoom pod
Imperative Care has announced the launch of its Zoom POD aspiration tubing—the company’s latest innovation in elevating stroke care. This is the newest addition...

Nevro announces publication of 12-month data on high-frequency SCS for non-surgical...

Nevro Corporation has announced online publication of 12-month data from the SENZA-NSRBP randomised controlled trial (RCT) in Journal of Neurosurgery: Spine. These data show that...

ISC 2022: Global EXCELLENT study “shows how much stroke thrombectomy has...

Mechanical removal of blood clots reduced post-stroke disability in nearly half of “all-comer” real-world stroke patients in a global study, according to preliminary late-breaking...

NovaGuide intelligent ultrasound found to significantly improve right-to-left shunt detection

NovaSignal Corporation has announced the results of a multicentre, prospective, single-arm study indicating that the company’s autonomous NovaGuide intelligent ultrasound is three times more...

New data presented at ISC 2022 further validate real-world impact of...

viz series d
Data from several new studies presented at the recent International Stroke Conference (ISC 2022; 9–11 February, New Orleans, USA) further validate the “best-in-class” sensitivity and...

NeuroOne releases successful long-term recording data with novel electrode technology

NeuroOne Medical Technologies has announced that it successfully completed initial preclinical, long-term testing of recording capabilities on its thin-film platform electrode technology. In test...

Cerenovus launches Emboguard balloon guide catheter for acute ischaemic stroke

Cerenovus—a neurovascular firm that forms part of Johnson & Johnson Medical Devices Companies—has announced the launch of Emboguard, its next-generation balloon guide catheter to...

Mechanical thrombectomy shown to restore more function than medication alone following...

severe stroke thrombectomy
A new study from Japan has become the first randomised controlled trial (RCT) to demonstrate the effectiveness of endovascular mechanical thrombectomy procedures in patients...

NeuroNews’ top 10 most popular stories of January 2022

An exclusive interview with the North American Neuromodulation Society (NANS) president piqued the interest of NeuroNews’ readers through the first month of the year,...

Perfuze raises €22.5m in Series A funding for novel acute ischaemic...

Perfuze announced today that it has closed a €22.5 million Series A investment round—the proceeds from which will be used to drive the next...

CereVasc receives FDA nod to study eShunt system in normal-pressure hydrocephalus...

CereVasc has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application to initiate a pilot trial...

Route 92 Medical announces first patient enrolment in SUMMIT MAX pivotal...

Route 92 Medical has announced the first patient enrolment in its SUMMIT MAX clinical trial—a randomised, controlled, multicentre study to evaluate the performance of...

Few cases and short timeframe required to overcome learning curve with...

A retrospective analysis of a prospectively maintained database has found that robot-assisted carotid artery stenting (CAS) is both safe and effective. Writing in Neurosurgical...

Intermittent theta-burst stimulation found to be effective and well-tolerated in Alzheimer’s...

The findings of a randomised controlled trial (RCT) have indicated that accelerated intermittent theta-burst stimulation (iTBS), administered to the left dorsolateral prefrontal cortex (DLPFC), is an...

Earl Slee joins Vesalio as new board observer and senior advisor...

vesalio
Vesalio has announced the addition of Earl Slee as a board observer and senior advisor to the company, effective immediately. According to a company...

Vena balloon distal access catheter gains Health Canada medical device licence

Vena Medical has announced the first Health Canada medical device licence for its new product, the Vena balloon distal access catheter, which combines the...

Reducing disability and death: What is next for stroke triage and...

stroke triage transport
Michael Chen (Rush University Medical Center, Chicago, USA) discusses the growing awareness around the need for timely interventions in stroke care in the USA,...

Updated medical policy expands patient access to Abbott’s DRG stimulation technology

Abbott announced today that UnitedHealthcare (UHC)—the largest private health insurance company in the USA—has updated its ‘Implanted electrical stimulator for spinal cord’ medical policy...

Dolphin vagus nerve stimulation receives Health Canada approval as COVID-19 treatment

Center for Pain and Stress Research today announced that its Dolphin vagus nerve stimulation (VNS) device has received breakthrough approval from Health Canada—making it...

Researchers pave way for adaptive DBS treatment after identifying OCD-associated brain...

In an effort to improve treatment for obsessive-compulsive disorder (OCD), a team of researchers has—for the first time, according to a Brown University (Providence,...

Galvani Bioelectronics announces first investigational treatment of rheumatoid arthritis using splenic...

Galvani Bioelectronics has announced that the first patient with rheumatoid arthritis (RA) has been treated through stimulation of the splenic nerve using its novel...

Rebus Esper platform leveraged to create “cell atlas” of brain vasculature...

Rebus Biosystems, an Illumina Ventures-backed life science technology firm, has announced the publication of a study in Science highlighting its Rebus Esper platform’s ability to spatially...

FDA issues two final guidances for including patient perspectives in medical...

The US Food and Drug Administration (FDA) has issued two final guidances providing recommendations for including patient perspectives in medical device clinical studies.   As...

NANS 2022: New 18-month data show durability of high-frequency SCS for...

senza-pdn study
This year’s North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA) saw 18-month data from SENZA-PDN—a randomised controlled trial (RCT) evaluating the...

Brainomix launches e-Stroke 11 to enhance stroke network communications and workflow

Brainomix has announced the launch of e-Stroke 11, the latest version of the company's AI-powered stroke imaging platform. According to a Brainomix press release,...

Salim Hayek

Salim Hayek is chief of the Division of Pain Medicine at University Hospitals of Cleveland and a professor in Case Western Reserve University’s Department...

Feinstein Institutes scientists develop “first-of-its-kind” wireless neuromodulation device for research

Engineers and researchers in the Institute of Bioelectronic Medicine at the Feinstein Institutes for Medical Research have developed a novel, fully implantable, wireless bidirectional vagus nerve stimulation (VNS)...

NIH launches first phase of US$9.8 million competition to accelerate development...

The National Institutes of Health (NIH) has launched the first phase of the Neuromod Prize—a US$9.8 million competition to accelerate the development of neuromodulation therapies....

Bendit announces first-in-human use of Bendit21 neurovascular catheter in the USA

Bendit Technologies has announced the successful first use in the USA of its Bendit21 neurocatheter in a life-saving treatment. The case was completed at the University...

Latest data reinforce evidence on safety and effectiveness of Contour intra-aneurysmal...

cerus study
Fresh data from the CERUS study—the first multicentre clinical trial evaluating safety and effectiveness outcomes with the Contour neurovascular system (Cerus Endovascular)—have indicated “encouraging...

Large real-world analysis deems Nerivio safe and effective in migraine treatment

Theranica has announced a new peer-reviewed study analysing the efficacy, safety and sustainability of remote electrical neuromodulation (REN) as a standalone, and medication-adjunct, treatment...

Nevro announces clinical data reinforcing significant and durable benefits of 10kHz...

Nevro Corporation has announced the results from data presentations at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA) supporting...

Medtronic announces results showing meaningful pain relief using DTM SCS endurance...

Medtronic has announced three-month results from an on-label, prospective, multicentre study showing meaningful pain relief using DTM SCS endurance therapy—a modified, lower-energy variation of the...

NANS 2022: Telehealth to play key role in improving patient access...

telehealth neuromodulation
COVID-19 may have held a defining role in the “rebirth” of telehealth and remote care models in the USA, but their utility in improving...

Novel neuromodulation technique could be “gamechanger” in treatment-resistant depression

saint depression treatment
Stanford accelerated intelligent neuromodulation therapy (SAINT)—a novel, high-dose intermittent theta-burst stimulation (iTBS)—was found to be safe and more effective than sham stimulation in a...

American Academy of Neurology provides ethical guidance on consent for people...

The American Academy of Neurology (AAN) has issued a position statement for neurologists on how to navigate consent issues for people who have experienced acute ischaemic...

First patient implanted in integrated spinal fusion and DRG stimulation proof-of-concept...

SynerFuse has announced the first implantation in the company's proof-of-concept study evaluating the safety and tolerability of simultaneously implanting spinal fusion hardware and a dorsal...

Evasc Neurovascular announces enrolment of first patient in French eClips study

Evasc Neurovascular has announced enrolment of the first patient in its eClips safety, feasibility and efficacy study (EESIS-FR) in France. The study will be...

Dedicated primary care can reduce stroke risk in seniors by more...

ChenMed has announced results from a three-year study of nearly 60,000 patients, showing 22% lower incidence of primary stroke among those having benefitted from...

FDA grants Breakthrough Device designation to Wavegate for StimuLux system

Wavegate Corporation has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for its StimuLux optical reflectometry system for closed-loop...

Medtronic announces schedule for sponsored presentations at NANS 2022

Medtronic has announced its schedule for presentations at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA). According to a press...

Study indicates aneurysm embolisation strategy can be optimised using 3D-printed, patient-specific...

Endovascular neurosurgery rehearsals using 3D-printed, patient-specific aneurysm models have demonstrated the ability to optimise embolisation strategy, as per the findings of a study published...

NeuroNews’ top 10 most popular stories of December 2021

In the lead up to the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA), the topic of neuromodulation featured prominently among...

Mainstay Medical announces positive efficacy and safety outcomes from ReActiv8-B trial

Mainstay Medical has announced the publication of two-year patient outcomes data from its pivotal ReActiv8-B clinical trial. The data, which are published in Neuromodulation:...

Saluda announces sustained, long-term pain relief results with closed-loop SCS in...

Saluda Medical today announced long-term results from its double-blind, Level 1 EVOKE trial, which have been published in JAMA Neurology and demonstrate superior, sustained pain...

Boston Scientific to present new data on advances in chronic pain...

Boston Scientific has announced key data that will be featured at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA)....

NeuroNews issue 44 – US

Highlights:  Insight from the "largest prospective study to date" of the p64 flow modulation device (phenox) The latest clinical data on endovascular therapy for...

NeuroNews issue 44 – EU

Highlights:  Insight from the "largest prospective study to date" of the p64 flow modulation device (phenox) The latest clinical data on endovascular therapy for...

iMediSync unveils “world’s first” integrated wireless brain EEG solution at Consumer...

iMediSync recently showcased its comprehensive electroencephalogram (EEG) solution, designed to perform brain screening and predictive analysis of potential mental conditions in just 10 minutes,...

Enabling new possibilities in stroke treatment with Stream technology

perflow stream devices
This advertorial is sponsored by Perflow. The StreamTM family of products (Perflow) is a range of dynamic neurothrombectomy net devices designed to give physicians greater...

Wallaby Medical launches Avenir coil system for haemorrhagic stroke treatment in...

Wallaby Medical has partnered with Japan Lifeline (JLL) to bring its Pharmaceuticals and Medical Devices Agency (PMDA)-approved Avenir coil system to the Japanese market....

Abbott announces expanded MRI compatibility for Proclaim XR spinal cord stimulation...

Abbott has announced that the US Food and Drug Administration (FDA) has approved new, expanded magnetic resonance imaging (MRI) compatibility for its Proclaim XR spinal cord...

Patient assent and lack of evidence among key ethical concerns identified...

paediatric deep brain stimulation
A study intended to gain insight into prevailing ethical issues surrounding the use of deep brain stimulation (DBS) in adolescents with obsessive-compulsive disorder (OCD)...

Worldwide stroke rates dip slightly over time, but overall numbers remain...

The worldwide incidence and mortality rates for stroke decreased slightly from 1990 to 2019, but the overall numbers remain high—especially in high- and middle-income...

Current gaps and barriers in patient access to spinal cord stimulation

spinal cord stimulation patient access
Maricela Schnur (St Luke’s Hospital, Duluth, USA) highlights a handful of socioeconomic disparities, racial differences, and psychological and psychiatric factors, that currently present difficulties...

CyberKnife robotic radiosurgery system approved for treatment of trigeminal neuralgia in...

Accuray has received approval from the Japanese Ministry of Health, Labor and Welfare (Shonin) to market the CyberKnife robotic radiosurgery system for the treatment of...

BRAIN 2021: In silico clinical trials likely to play complementary role...

in silico clinical trials
In silico studies involving virtual participants hold great potential in the neurovascular field—and the broader medical industry—with their future role in the generation of...

US physicians “among nation’s first” to implant neurostimulator technology for advanced...

Doctors at St David's Medical Center in Austin, USA recently implanted a new neurostimulator technology in patients to help treat advanced heart failure—and are...

ClaroNav receives Chinese regulatory clearance for Navient neuro-navigation system

ClaroNav Kolahi—a subsidiary of ClaroNav—has received regulatory clearance from the National Medical Products Administration (NMPA) to market and sell its Navient cranial model in...

Time savings, cost reductions and improved patient outcomes all key benefits...

artificial intelligence stroke care
Artificial intelligence (AI) and the role it can play in improving acute ischaemic stroke care protocols took centre stage at the Barts Research and...

First patient enrolled in pivotal EMAGINE trial of electromagnetic field therapy...

BrainQ has announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital (Washington, USA) in the pivotal, randomised, double-blind, multicentre EMAGINE...

NeuroNews’ top 10 most popular stories of November 2021

The latest technologies and research breakthroughs in neuromodulation feature prominently among our top stories for November, while two momentous announcements from the neurosurgery field—courtesy...

Mouse study suggests neuromodulation of certain nerve cells can help regenerate...

Johns Hopkins Medicine researchers say they have new evidence from mouse experiments that manipulating certain nerve cells, or the genes that control them, with...

CereVasc announces publication of first-in-human case report with eShunt system

CereVasc has announced the publication of a case report detailing the first treatment in a study of its eShunt system—an investigational device intended to...

Passive recharge burst SCS provides sustainable improvements in pain and psychosocial...

Passive recharge burst spinal cord stimulation (B-SCS) can alleviate pain intensity and psychological distress, and improve physical function and health-related quality of life out...

MicroTransponder receives best new product award for Vivistim system

MicroTransponder today announced that its Vivistim paired vagus nerve stimulation (VNS) system has won the Neurotech Reports Gold Electrode Award for best new product. This announcement...

FluxWear to debut wearable neuromodulation device at 2022 Consumer Electronics Show

FluxWear has announced that it will be demonstrating its first product at the Consumer Electronics Show (CES) early next year (5–8 January 2022, Las...

AURORA: Evidence in favour of thrombectomy beyond six hours strengthened by...

aurora meta-analysis
Evidence favouring endovascular therapy (EVT) in anterior circulation stroke patients presenting with reversible cerebral ischaemia in the later time window (beyond six hours) from...

New protocol may reduce need for psychological assessments prior to neuromodulation...

Researchers at Toronto Western Hospital in Canada have proposed a protocol that may precede in-person assessments prior to patients receiving neuromodulation therapies. Their protocol...

Wyss Center, Inselspital Bern announce clinical trial of long-term brain monitoring...

epios brain-monitoring technology
As part of a recently announced clinical trial, brain signal recording with the Wyss Center for Bio and Neuroengineering’s novel brain-monitoring technology, its subscalp...

Nevro announces three key data publications on novel painful diabetic neuropathy...

Nevro has announced three clinical data publications on treating painful diabetic neuropathy (PDN) with 10kHz spinal cord stimulation (SCS) therapy—including 12-month data from the...

Incidence of brain complications among hospitalised COVID-19 patients revealed in global...

The largest multi-institutional international study to date on brain complications associated with COVID-19 has found that approximately one in 100 patients hospitalised following SARS-CoV-2...

White matter hyperintensities may hold key to identifying long-term harm in...

A new study has found that brain scans taken during the lifetimes of athletes in contact sports, compared to changes in their brains at...

Large prospective study demonstrates high efficacy and low mortality rates with...

Diversion-p64 study
The Diversion-p64 study—the largest prospective study using the p64 flow modulation device (phenox) to date—has demonstrated that the device has a high level of...

Intranasal delivery of microrobots could trigger new possibilities in treating neurological...

A research team in South Korea has developed and successfully implanted a microrobot device into the brain tissue of mice through the intranasal pathway,...

SedLine-guided general anaesthesia may reduce post-carotid endarterectomy delirium

Masimo has announced the findings of a prospective study published in Frontiers in Neurology in which Na Xu and colleagues at Capital Medical University in Beijing,...

Antibiotic envelopes appear safe and effective in decreasing SCS surgical site...

scs surgical infection
Antibiotic impregnated envelopes appear to be a safe and effective modality for decreasing surgical site infection risks in spinal cord stimulation (SCS) implantation, according...

Robocath successfully performs first carotid stenting in France with R-One robot

Robocath today announced its successful first robotic carotid stenting at Rennes University Hospital. This breakthrough in the neurovascular field was performed on 16 November...

Accuray announces two decades of clinical data on CyberKnife robotic radiotherapy...

Accuray has announced the publication of more than two decades of globally-driven clinical data supporting the use of its CyberKnife robotic radiotherapy platform for the delivery...

NeuroNews’ top 10 most popular stories of October 2021

New data on stroke rehabilitation and chronic migraine therapy caught the eye of NeuroNews' readers in October, as did notable discussions from industry-leading events...

Viz.ai debuts AI-powered cerebral aneurysm detection technology at SVIN 2021

viz series d
At this year’s Society of Vascular and Interventional Neurology annual meeting (SVIN 2021; 17–20 November, Phoenix, USA and virtual), Viz.ai introduced Viz ANX, a...

BlueWind Medical completes patient enrolment in OASIS study

BlueWind Medical has announced the successful completion of patient enrolment in the OASIS pivotal clinical study that will assess the company’s innovative Renova iStim...

Hispanic stroke patients experience poorer post-thrombectomy outcomes than white counterparts

hispanic stroke patients
A study conducted by neurology researchers at University of Texas Southwestern (UTSW) Medical Center has found lower-quality functional outcomes for Hispanic ischaemic stroke patients...

Cascade device provides the best of both worlds in treating cerebral...

This advertorial is sponsored by Perflow. The Cascade Net (Perflow)—a non-occlusive remodelling net used in the treatment of cerebral aneurysms—is the first and only device...

NeuroPace gains IDE approval to launch pivotal study of neuromodulation therapy...

NeuroPace has announced that it has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate the NAUTILUS...

Research shows brain rhythm changes occur ‘within minutes’ of DBS surgery...

New research published in Translational Psychiatry presents evidence that brief intraoperative exposure to therapeutic deep brain stimulation (DBS) at the time of implantation surgery induces...

Insightec announces FDA approval of Exablate Neuro device to treat Parkinson’s...

exablate neuro fda approval
Insightec has announced that the US Food and Drug Administration (FDA) has approved the Exablate Neuro device for treating advanced Parkinson's disease patients suffering from...

Return to work and depressive symptoms in young stroke survivors

post-stroke depression
Matthias Volz (University of Kassel, Kassel, Germany), Simon Ladwig and Katja Werheid (both Humboldt-Universität zu Berlin, Berlin, Germany) discuss the burden of post-stroke depression...

Nevro announces plans to appeal jury decision in spinal cord stimulation...

nevro patent infringements
Nevro Corporation has provided an update on its position following a Delaware jury’s decision to award Boston Scientific US$20 million over patent infringements. The...

Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions...

rapid medical distals study
Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first ever trial...

Rune Labs and Medtronic partner to improve understanding of neurostimulation with...

medtronic rune labs
Rune Labs, a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and psychiatric diseases, and global healthcare...

New study finds e-Stroke software shortens treatment times and improves functional...

A new study presented at the 13th World Stroke Congress (WSC 2021; 28–29 October, virtual) found that the implementation of Brainomix's e-Stroke software resulted in...

Magnus Medical announces Breakthrough Device designation for novel depression treatment and...

Magnus Medical has announced that the US Food and Drug Administration (FDA) has granted the company Breakthrough Device designation for its individualised, rapid-acting, non-invasive...

Increased experience associated with shorter procedure times and better reperfusion rates...

operator experience thrombectomy
Increasing levels of experience in performing mechanical thrombectomies have been associated with shorter procedural duration and better reperfusion rates in a multicentre study—with the...

World Stroke Day 2021: Get Ahead of Stroke campaign pushes for...

world stroke day 2021
On World Stroke Day—29 October 2021—physicians from the Get Ahead of Stroke campaign are urging lawmakers to update triage and transport protocols. They are...

World Stroke Day 2021: Survey finds 65% of hospitals worldwide do...

On the eve of World Stroke Day (29 October), the World Stroke Organization (WSO) has called for urgent improvements to the treatment of stroke...

Phenox expands acute ischaemic stroke portfolio with global launch of pRESET...

Phenox has added to its extensive technology portfolio with the introduction of the pRESET 6-50 mechanical thrombectomy device for the treatment of acute large...

Biomodex launches synthetic clot product for neurovascular training

Biomodex, a company specialising in biorealistic haptic simulators for physician training and rehearsals, has announced the launch of Thrombotech—a new, hydrogel-based synthetic clot product...

SPR Therapeutics announces expanded FDA clearance for SPRINT peripheral nerve stimulation...

SPR Therapeutics has obtained clearance from the US Food and Drug Administration (FDA) of a broader indication for the usage of its SPRINT peripheral...

Study indicates safety and efficacy of remote electrical neuromodulation in chronic...

cartbind study
Theranica has announced the publication of a new, peer-reviewed article in Pain Reports detailing a study assessing its novel, drug-free treatment option for chronic...

North Carolina updates stroke triage and transport protocol

North Carolina has updated its emergency stroke care protocol—a move applauded by the Get Ahead of Stroke campaign. The protocol, which went into effect...

Neuvotion secures more than US$1 million in seed funding to commercialise...

Neuvotion has announced that it has received more than US$1 million in seed funding. The Long Island Angel Network, an organised group of individual,...

MindMaze partners with Royal Buckinghamshire Hospital to bring novel stroke rehab...

mindpod uk
MindMaze Healthcare has announced the first UK partnership for its novel MindPod platform to target cognitive and motor restoration in stroke patients. This new partnership...

NeuroNews’ top 10 most popular stories of September 2021

Highlights from this year's European Stroke Organisation Conference (ESOC 2021; 1–3 September, virtual), Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021;...

Imperative Care enrols first patient in trial evaluating Zoom 88 Large...

imperative zoom pod
Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...

Wyss Center announces CE mark for Epios Cloud brain data visualisation...

The Wyss Center has announced CE mark Class I medical device approval for its Epios Cloud software—a web-based application for the online storage, processing...

NeuroVasc announces enrolment of first patient in ENVI-SR mechanical thrombectomy system...

neurovasc envi-sr trial china
NeuroVasc Technologies has announced that the first patient has been treated in a pivotal randomised controlled trial (RCT) in China, which will evaluate the...

Stroke study reveals optimal timing and intensity for arm and hand...

stroke rehabilitation study
A phase II, randomised clinical trial has found that the optimal period for intensive rehabilitation of arm and hand use after a stroke should...

High-frequency SCS takes the stage to relieve chronic pain from diabetic...

scs diabetic neuropathy
Following the recent approval of the Senza system (Nevro) by the US Food and Drug Administration (FDA), Erika A Petersen (Little Rock, USA) discusses the...

Medtronic receives CE mark approval for radial artery access portfolio

Medtronic receives CE mark approval for radial artery access portfolio
Medtronic today announced it has received CE mark approval for its radial artery access portfolio, which includes the Rist radial access selective catheter and the Rist...

Indian health ministry approves Exablate Neuro focused ultrasound platform

exablate neuro fda approval
Insightec has announced its incisionless neurosurgery platform, the Exablate 4000, has received market approval by the Central Drugs Standard Control Organization (CDSCO)—part of the Ministry...

Medtronic recalls Pipeline Flex embolisation devices over risk of delivery system...

medtronic pipeline flex recall
Medtronic has issued a recall of its Pipeline Flex embolisation device and Pipeline Flex embolisation device with Shield technology products due to a risk...

FAST SCS innovation producing results “rarely seen before” in the world...

This advertorial is sponsored by Boston Scientific and is only intended for readers in Europe. Fast-acting sub-perception therapy (FAST™)—a novel innovation in the field of...

NeuroOne successfully completes feasibility study of Evo ablation electrode

NeuroOne Medical Technologies has announced the successful completion of an animal feasibility study of its combination recording and ablation technology at T3 Labs and...

LINNC 2021: ESCAPE-NEXT trial may bring “dream” of combining neuroprotection with...

evt neuroprotection
At this year’s LINNC Paris Course (14–16 September, Paris, France and virtual), audiences heard that the ESCAPE-NEXT trial (sponsored by NoNO Inc.), which has already started enrolling...

Else Charlotte Sandset

else charlotte sandset
Else Charlotte Sandset is a consultant neurologist in the Stroke Unit of the Department of Neurology at Oslo University Hospital, and chair of the...

Rhaeos awarded US$4 million NIH grant to expand sensor technology for...

Rhaeos has been awarded a US$4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) programme through the...

ESMINT 2021: COATING study “badly needed” to assess surface modification of...

coating study phenox
This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...

Neuros Medical completes enrolment in QUEST pivotal study of novel post-amputation...

neuros quest study
Neuros Medical—a medical device company developing novel high-frequency nerve block technology for patients with intractable post-amputation pain—has announced the completion of enrolment in its pivotal QUEST...

Study indicates efficacy of hyperbaric oxygen therapy in reversing Alzheimer’s activators

A new study, published in the peer-reviewed medical journal Aging, marks the first time non-pharmaceutical clinical exploration has proved efficacious in reversing the main...

Novel teleproctoring platform successfully used for neuroendovascular fellowship training

neuroendovascular teleproctoring
A novel augmented reality (AR) platform (Proximie) has been successfully used to teleproctor a neuroendovascular fellow during complex interventional and diagnostic procedures. That is...

CRISP study indicates clinical benefit of non-paraesthesia-based approaches in burst SCS...

crisp study scs
The CRISP (Comparison of paraesthesia mapping to anatomic midline-based burst programming strategies) study, published in Neuromodulation: Technology at the Neural Interface, has found that...

Sensome begins first-in-human trial of AI-powered stroke guidewire

sensome clot out
Sensome has announced enrolment of the first patients in the multicentre, first-in-human CLOT OUT study, which will evaluate the safety and performance of the...

NeuroNews issue 43 – US

Highlights:  A closer look at the latest clinical data regarding flow diversion technologies – including new insights on the Flow redirection endoluminal device (FRED;...

NeuroNews issue 43 – EU

Highlights:  A closer look at the latest clinical data regarding flow diversion technologies - including new insights on the Flow redirection endoluminal device (FRED;...

TCAR may be associated with favourable outcomes for treatment of restenotic...

tcar restenotic carotid lesions
Transcarotid artery revascularisation (TCAR; Silk Road Medical) may be associated with favourable in-hospital outcomes for the treatment of restenotic carotid lesions after carotid endarterectomy...

“Welcome and exciting”: Evidence mounts in favour of flow diversion technologies

flow diverter devices
Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....

Neuromod Devices appoints Diarmuid Flavin as COO to boost expansion of...

Diarmuid Flavin
Neuromod Devices has announced the appointment of Diarmuid Flavin as chief operating officer (COO). Flavin brings more than 25 years of global leadership experience...

Direct mechanical thrombectomy fails to show non-inferiority compared with IV t-PA...

swift-direct trial thrombectomy
The preliminary results of the SWIFT-DIRECT (Solitaire with the intention for thrombectomy plus IV t-PA versus direct Solitaire stent-retriever thrombectomy in acute anterior circulation...

Flying intervention teams lead to higher EVT rates and reduced time...

flying intervention teams stroke
Flying teams of interventionists directly to a primary stroke centre to perform endovascular therapy (EVT)—as opposed to waiting for the patient to be transferred...

NeuroOne Medical Technologies gains FDA 510(k) clearance for Evo SEEG electrode

neuroone evo technology
NeuroOne Medical Technologies—a company focused on improving surgical care options and outcomes for patients with neurological disorders—has announced that it has received US Food...

NeuroNews’ top 10 most popular stories of August 2021

An exclusive interview covering a novel endovascular treatment option for communicating hydrocephalus (CH), the latest research involving deep brain stimulation (DBS) therapies, and data...

ESOC 2021: AI can calculate personalised risk of having another stroke

Artificial intelligence (AI) can be used to give stroke patients a personalised and more accurate assessment of their risk of suffering a recurrence, according...

ESOC 2021: Non-traditional risk factors for heart attack and stroke rising...

stroke risk factors
Work stress, sleep disorders, and fatigue—which are regarded as non-traditional risk factors for heart attack and stroke—are rising more steeply among women than men,...

MicroTransponder gains FDA approval for first-of-its-kind VNS system to improve stroke...

vivistim system
MicroTransponder has announced US Food and Drug Administration (FDA) premarket approval of the Vivistim paired vagus nerve stimulation (VNS) system, which—according to a company...

Presidio Medical publishes clinical and preclinical research on ULF neuromodulation therapy

ulf neuromodulation
Presidio Medical has announced that research involving its novel ultra-low frequency (ULF) neuromodulation therapy has been published in Science Translational Medicine. The publication, titled...

DTM SCS: A unique, tailored and highly effective therapy option for...

dtm scs therapy
Michael Fishman (Wilmington, USA) discusses the benefits of Differential Target Multiplexed spinal cord stimulation (DTM SCS; Medtronic)—when compared to more conventional SCS therapy options—and...

Qure.ai lands second FDA clearance for AI-based brain scan technology

qure.ai
Qure.ai has announced US Food and Drug Administration (FDA) 510(k) clearance for its brain computed tomography (CT) quantification product qER-Quant. Clinicians in the USA...

Postoperative admission of adult craniotomy patients to neuroscience ward reduces length...

craniotomy neuroscience ward
Admitting adult craniotomy patients without significant comorbidities, who are expected to have a short length of stay, to the neuroscience ward has been associated...

Synchron announces US$10 million NIH grant for US COMMAND trial

synchron stentrode safety
The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...

SyntheticMR and Siemens Healthineers extend collaboration with new license agreement

syntheticmr siemens healthineers
SyntheticMR has entered a general software license agreement for distribution with Siemens Healthineers. The agreement enables Siemens Healthineers to market, sell and distribute SyntheticMR's...

Neurosurgery with Surgical Theater’s VR and AR technologies set for first...

surgical theater israel
Rambam Healthcare Medical Center in Haifa, Israel is set to become the first medical centre in Israel to use virtual reality (VR) and augmented...

Q’Apel Medical launches Armadillo radial artery access platform

Q'Apel Medical announced today the launch of the Armadillo radial access system—the latest application of its SelectFlex technology and part of the SelectFlex family...

Behavioural interventions and more holistic approach signal “paradigm shift” in latest...

aha/asa secondary stroke prevention
In May 2021, the American Heart Association (AHA)/American Stroke Association (ASA) updated one of its flagship guidelines—the secondary prevention of stroke guideline—for the first...

Temporary SCS could represent “new paradigm” in preventing atrial fibrillation

In a randomised pilot study, temporary spinal cord stimulation (SCS) has demonstrated efficacy in the suppression of postoperative atrial fibrillation (AF) following coronary artery...

Insightec announces Seoul National University Hospital is installing its Exablate Neuro...

exablate neuro fda approval
Insightec has announced that Seoul National University Hospital (SNUH) is installing the company’s Exablate Neuro (Exablate 4000) platform—which uses focused ultrasound to ablate targets...

William Mack

william mack
William Mack is a professor of neurosurgery and vice-chair of academic affairs in the Department of Neurological Surgery at the University of Southern California...

Benefits of EVT for basilar artery occlusion “cannot be excluded” following...

basics evt trial
A randomised controlled trial (RCT) involving 300 patients found that functional outcomes among basilar artery occlusion stroke patients “did not differ significantly” with endovascular...

Michael Chen becomes 26th president of SNIS

michael chen snis president
Michael Chen, a neurointerventionist at Rush University Medical Center in Chicago, USA, has been named the president of the Society of NeuroInterventional Surgery (SNIS)...

Fluid Biotech raises US$4.7 million in oversubscribed seed funding round

fluid biotech
Fluid Biotech, a medical device start-up company based in Calgary, Canada, has announced the completion of an oversubscribed seed fundraising round totalling US$4.7 million—and...

Time is brain: Travelling stroke team enables faster treatment and better...

travelling stroke team
In a pilot programme in New York City, USA, a mobile interventional stroke team (MIST) travelled directly to patients to perform emergency stroke surgery...

Flow Neuroscience receives Series A funding to advance tDCS depression treatment

flow neuroscience funding
Flow Neuroscience, the creator of what is currently Europe’s only medically approved transcranial direct current stimulation (tDCS) device and behavioural therapy app for depression,...

SpinTech earns FDA clearance for rapid, quantitative brain-imaging technology

spintech stage
The US Food and Drug Administration (FDA) has granted 510(k) approval for STAGE (Strategically acquired gradient echo), the latest magnetic resonance imaging (MRI) technology...

Phenox highlights benefits of longer stentriever devices with new study results

phenox longer stentriever
Following its acceptance into Frontiers in Neurology, Phenox has announced the results of a paper exploring the benefit of choosing a longer stentriever for...

Revolution in neurotherapy? Spotlight on focused ultrasound at 2021 EAN congress

focused ultrasound neurotherapy
While focused ultrasound is by no means a brand-new innovation in the field of neurotherapy—having first been deployed in the 1950s, if not earlier,...

FRED flow diverter safe and effective in treatment of “appropriately selected”...

fred flow diverter
The Flow Redirection Endoluminal Device stent system (FRED; MicroVention)—a flow diverter used to treat intracranial aneurysms—has been deemed safe and effective for this indication,...

Allegheny Health Network initiates clinical trial exploring use of DBS to...

dbs obesity treatment
A team of physicians at Allegheny Health Network (AHN) in Pittsburgh, USA has received US Food and Drug Administration (FDA) approval to begin the...

NeuroNews’ top 10 most popular stories of July 2021

top 10 NeuroNews July
A new technology to help surgeons reduce the risk of aneurysm regrowth, Philips’ most recent contributions to the field of stroke care, and evidence...

Long-term effectiveness of STN-DBS for Parkinson’s confirmed with 15-year follow-up study

dbs long-term effectiveness
New findings published in Neurology, the medical journal of the American Academy of Neurology (AAN), have confirmed the long-term effectiveness of deep brain stimulation...

Synchron given green light to begin US study of endovascular brain-computer...

synchron stentrode safety
The Stentrode motor neuroprosthesis, developed by Synchron, has taken another step towards becoming the world’s first commercially available, endovascular brain-computer interface (BCI) technology after...

Gender disparity in comprehensive stroke centre routing highlighted at SNIS 

women comprehensive stroke centre
Women may be less likely than men to be sent to a comprehensive, or “Level 1”, stroke centre for emergent large vessel occlusion (ELVO)...

SNIS 2021: Remote stroke interventions raise several unique ethical challenges

remote stroke interventions
At the Society of NeuroInterventional Surgery’s 18th annual meeting (SNIS; July 26–29 2021, Colorado Springs, USA and virtual), Jeffrey Saver, professor of Neurology at...

Using new-generation CB-CT imaging tests may shorten time to surgery for...

Using a different type of computed tomography (CT) scan may reduce the time to essential surgery for patients with the deadliest kind of strokes—emergent...

Research shows new surgical technology may help reduce brain aneurysm regrowth

A new tool for treating brain aneurysms may protect artery blood flow during surgery and reduce the risk of aneurysm regrowth, according to a...

Black stroke patients undergo neuroendovascular surgery less often than white patients,...

Black patients with stroke are less likely than white patients to undergo a potentially lifesaving, minimally-invasive thrombectomy procedure to remove blood clots from arteries...

Neuro42 closes US$6.5 million Series A financing round

neuro42
Neuro42, a US medical technology start-up focused on magnetic resonance imaging (MRI) and robotics, has announced the close of a US$6.5 million Series A...

Race among factors that predict how quickly patients get to stroke...

stroke care centres
Race, in combination with other factors, predicted how quickly individuals with stroke got to care centres to receive necessary neuroendovascular surgery, including thrombectomy, according...

Cerenovus to unveil new data and showcase stroke care innovations at...

cerenovus stroke care
Cerenovus, a neurovascular firm that forms part of The Johnson & Johnson Medical Devices Companies, will showcase its latest innovations in stroke care at...

Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...

carotid disease stenting
Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients. Best...

Omniscient Neurotechnology launches Quicktome brain-mapping platform following FDA clearance

quicktome omniscient neurotechnology
Omniscient Neurotechnology has received US Food and Drug Administration (FDA) 510(k) clearance for Quicktome—a digital brain-mapping platform that allows neurosurgeons to visualise and understand...

Omniscient Neurotechnology raises AUD$40 million in Series B financing

Omniscient Neurotechnology
Omniscient Neurotechnology, a Sydney-based brain-mapping technology company, has announced the completion of a AUD$40 million Series B financing round. The funding will allow Omniscient...

Nevro announces FDA approval of 10kHz high-frequency SCS therapy for painful...

Nevro has announced receipt of US Food and Drug Administration (FDA) approval for its Senza system for the treatment of chronic pain associated with...

NeuroNews issue 42 – US

Highlights:  Insight on the benefits of endovascular therapy (EVT) for basilar artery occlusion from the BASICS (Basilar artery international cooperation study) trial Why the...

NeuroNews issue 42 – EU

Highlights:  Insight on the benefits of endovascular therapy (EVT) for basilar artery occlusion from the BASICS (Basilar artery international cooperation study) trial Why the...

ASA highlights value of comprehensive, patient-centred primary care after stroke

primary stroke care ASA
In a new scientific statement entitled “Primary Care of Adult Patients After Stroke”, the American Stroke Association (ASA)—a division of the American Heart Association...

How stimulation is changing the future of mental health treatment

tdcs mental health treatment
Daniel Månsson (Flow Neuroscience, Malmö, Sweden) outlines the benefits held by transcranial direct-current stimulation (tDCS) in the treatment of depression—and how clinical evidence supporting...

Brainomix launches AI stroke software across Poland under POLKARD initiative

brainomix poland
Brainomix has deployed its flagship artificial intelligence (AI)-based e-Stroke software across the majority of the largest comprehensive stroke centres in Poland, allowing the company...

BlueWind Medical enrols 100th patient in OASIS study of Renova iStim...

renova istim
BlueWind Medical, a company making neuromodulation medical devices for the treatment of overactive bladder, has announced that the 100th patient has been enrolled in...

Repeated clot retrieval attempts linked to poorer functional outcome in acute...

repeated clot retrieval stroke
Repeated clot retrieval attempts are associated with an increased rate of emboli to new territory (ENT) and greater infarct growth—resulting in poorer functional outcomes...

Philips enrols first patient in WE-TRUST stroke study to assess new...

WE-TRUST study philips
Royal Philips has announced that the first patient has been enrolled in the WE-TRUST (Workflow optimisation to reduce time to endovascular reperfusion for ultra-fast...

Robocath, Rennes University Hospital partner with Philips France to research stroke...

robocath stroke research
Robocath and Rennes University Hospital have announced they are launching a co-development research programme using robotics to improve treatments for stroke patients. With the...

Insightec announces approval of Exablate Neuro focused ultrasound platform in Singapore

exablate neuro singapore
Insightec has announced approval of its Exablate Neuro platform by the Health Sciences Authority (HSA) in Singapore. The Exablate Neuro (Exablate 4000) platform uses...

Men and women respond equally well to spinal cord and DRG...

spinal cord stimulation men women
In a study intended to explore gender differences in patients with failed back surgery syndrome (FBSS) or chronic visceral pain, men and women have...

Neuros Medical gains FDA Breakthrough Device designation for Altius nerve block...

neuros quest study
Neuros Medical has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for the use of its novel, high-frequency nerve block...

NeuroNews’ top 10 most popular stories of June 2021

neuronews top 10
Fresh evidence on the differences between directional and omnidirectional deep brain stimulation (DBS), as well as regulatory approvals for a new reperfusion catheter and...

Viz.ai receives CE mark to bring AI-powered stroke care software to...

viz series d
Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...

Mainstay Medical launches implantable restorative neurostimulation system in USA

mainstay reactiv8
Mainstay Medical has announced the limited US commercial launch of ReActiv8, its implantable restorative neurostimulation system to treat intractable chronic low back pain. The...

Flow diverter study with virtual participants “as effective as traditional clinical...

virtual flow diverter trials
A study involving virtual participants—rather than real patients—was “as effective as traditional clinical trials” in evaluating the treatment of brain aneurysms using a flow...

New Stroke Association report to “shine a light” on stroke care’s...

stroke association priorities
The Stroke Association has announced the top areas of research that need to be prioritised to improve stroke care. The announcement of these priorities—which...

Epipole joins €1.1 million AI project to diagnose intracranial pressure

epipole
Video retinal imaging company Epipole has announced it has begun working on a €1.1 million collaborative project to develop a technology solution for the...

Penumbra receives FDA clearance for RED 62 reperfusion catheter

penumbra red 62
Penumbra has announced US Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED 62 reperfusion catheter—the latest addition to the...

Stroke and heart condition patients want virtual healthcare to continue post...

virtual stroke care
After speaking with experts, reviewing current evidence, surveying people living with stroke or a heart condition, and funding a telephone poll of Canadians, the...

Sensome’s AI-powered stroke guidewire granted FDA Breakthrough Device designation

sensome clot out
Sensome has announced its Clotild Smart Guidewire System—designed to improve the treatment of ischaemic stroke patients—has been granted a Breakthrough Device designation by the...

Neuromodulation device for treating MS-related gait deficit receives FDA authorisation

pons fda approval
Cambridge Consultants and Helius Medical Technologies have confirmed their “groundbreaking" Portable Neuromodulation Stimulator (PoNS) device—developed for the short-term treatment of gait deficit due to...

Data from 1,000 aneurysms indicate Pipeline Embolization Device is safe and...

pipeline embolization device
The endovascular treatment of intracranial aneurysms using the Pipeline Embolization Device (PED; Medtronic) has been deemed safe and effective following a study involving data...

Medtronic announces FDA approval of recharge-free Vanta spinal cord stimulation implant

medtronic vanta
Medtronic has received US Food and Drug Administration (FDA) approval for Vanta—a high-performance, recharge-free implantable neurostimulator (INS) with a device life that can be...

Benefits found in directional DBS compared to omnidirectional stimulation for Parkinson’s...

Directional deep brain stimulation (DBS) has demonstrated benefits over omnidirectional DBS for the treatment of Parkinson’s disease in the largest prospective study in this...

Mitchell Elkind

mitchell elkind
Mitchell Elkind is a professor of Neurology and Epidemiology at Columbia University Irving Medical Center, and chief of the Division of Neurology Clinical Outcomes Research and Population...

FDA approves “first-of-its-kind” SenSight Directional Lead System for DBS therapy

Medtronic receives CE mark approval for radial artery access portfolio
Medtronic has announced US Food and Drug Administration (FDA) approval and first US implants of the SenSight Directional Lead System, which is used...

New algorithm could enable next-generation deep brain stimulation devices

next-generation dbs devices
By delivering small electrical pulses directly to the brain, deep brain stimulation (DBS) can ease tremors associated with Parkinson's disease or help relieve chronic...

Vesalio secures Class A funding to bolster stroke treatment portfolio

vesalio series a funding
Vesalio has successfully secured a Class A financing round. The company claims this funding will be utilised to support its ongoing US Investigational Device...

Higher incidence of severe stroke found in COVID-19 patients

covid-19 severe stroke
Among people who have strokes and COVID-19, there is a higher incidence of severe stroke as well as a higher incidence of stroke in...

NeuroNews’ top 10 most popular stories of May 2021

neuronews top 10
New industry partnerships, the potential for energy savings in neuromodulation and the contentious topic of vertebral artery stenting were among the top stories that...

Avicenna.AI receives CE mark for AI tool to assess stroke severity

stroke severity assessment ai
Medical imaging AI specialist Avicenna.AI has received CE mark certification for its CINA ASPECTS AI tool for stroke severity assessment. CINA ASPECTS automatically processes...

Clinical improvements seen following transvenous paraspinal vein embolisation for CSF hypotension

csf hypotension
A case series to assess transvenous paraspinal vein embolisation of cerebrospinal fluid (CSF)-venous fistulas—a novel treatment approach for spontaneous intracranial hypotension (SIH)—has resulted in...

RapidAI unveils prehospital solution to optimise cross-team workflow and improve patient...

RapidAI
RapidAI has announced the launch of its Rapid prehospital workflow solution for stroke, which optimises coordination between emergency medical services (EMS) providers and hospital...

Livestreamed procedures close distance between clinicians and trainees during pandemic

livestreamed surgeries
Phil Taussky outlines a simple yet effective livestreaming platform that holds benefits for neurosurgeons during the ongoing COVID-19 crisis. One of the challenges faced by...

HeMo Bioengineering receives China’s NMPA approval for Afentta aspiration catheter

hemo bioengineering afentta
HeMo Bioengineering, a Singapore-based medical device company with a focus on treating stroke patients, has announced that its Afentta intracranial thrombectomy aspiration catheter—a product...

Prevention based on first stroke cause can reduce risk of subsequent...

aha stroke prevention guidelines
Identifying the cause of a stroke or transient ischaemic attack (TIA)—sometimes called a “mini-stroke”—can lead to specific prevention strategies to reduce the risk of...

Noninferiority of thrombectomy alone further demonstrated in acute ischaemic stroke treatment

mechanical thrombectomy alone
The noninferiority of mechanical thrombectomy alone—compared to mechanical thrombectomy plus intravenous tissue plasminogen activator (IV-tPA)—for the treatment of acute ischaemic stroke has been demonstrated...

Study shows “major energy savings” can be achieved in spinal cord...

spinal cord stimulation chronic pain
The results of the HALO (High and low frequency options) study, which are published online in the scientific journal Neuromodulation: Technology at the Neural...

Chordate Medical receives CE mark to treat chronic migraine with neuromodulation...

chordate medical
Chordate Medical has received a CE marking that permits its Kinetic Oscillation Stimulation (KOS) technology to be marketed, sold and used for the treatment...

Medtronic, Viz.ai partner to bring “lifesaving” AI platform for stroke to...

viz.ai medtronic
Medtronic and Viz.ai have announced they are extending their successful US partnership to distribute Viz.ai’s "lifesaving" artificial intelligence (AI) software platform for stroke to...

First annual World Stroke Thrombectomy Day to be announced by SVIN...

world stroke day 2021
The Society of Vascular and Interventional Neurology (SVIN) Mission Thrombectomy 2020+ Initiative (MT2020+) will announce the first annual World Stroke Thrombectomy Day at the...

Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment

vesalio
US medical device company Vesalio has announced the start of enrolment in the Vesalio CLEAR study—an acute ischaemic stroke FDA investigational device exemption (IDE)...

rTMS found to be “well-accepted” for therapeutic use in psychiatric populations

rtms therapy georgia stillianesis
Psychiatric populations perceive the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) for mental health conditions to be beneficial, safe, and no more dangerous...

Perfuze announces CE mark and treats first patients with Millipede 088...

perfuze millipede 088
Neurovascular medical device company Perfuze has announced that the first five acute ischaemic stroke patients have been treated with its Millipede 088 clot aspiration...

Perflow Medical announces first clinical use of Stream17 Dynamic Neurothrombectomy Net

perflow medical stream17 device
Perflow Medical has announced the first successful clinical use of its Stream17 Dynamic Neurothrombectomy Net—a lower profile device designed to effectively treat haemorrhagic and...

CX 2021: Stenting should be reserved for the extracranial vertebral arteries...

vertebral artery stenting
Stenting is something that, for now at least, should be considered in the extracranial vertebral arteries only—and not the intracranial arteries—for symptomatic atherosclerotic stenosis,...

First US ischaemic stroke patients treated with Rapid Medical’s novel clot...

rapid medical TIGERTRIEVER
The first US patients have been treated with the FDA-cleared TIGERTRIEVER revascularisation device (Rapid Medical). TIGERTRIEVER is the first physician-adjustable stent retriever, according to...

IpsiHand System: New device for facilitating stroke rehabilitation gains FDA approval

IpsiHand System
The US Food and Drug Administration (FDA) has authorised marketing of a new device indicated for use in patients aged 18 and older undergoing...

Case report indicates 3D black blood vessel wall imaging can predict...

dr mohd fandi black blood vessel wall imaging
The early findings from a case report have highlighted the potential held by 3D black blood vessel wall post-contrast imaging to predict the outcomes...

Medtronic and Surgical Theater to provide first real-time AR platform for...

complex cranial procedures
Medtronic will partner with American health technology firm Surgical Theater to provide the first augmented reality (AR) platform for use in real time during...

UK charity funds “world-first” study into long-term COVID-19 impact on stroke

stroke association priorities
Leading UK charity the Stroke Association is funding what it claims will be the world’s first study to determine the long-term impact of COVID-19...

First patient enrolled in MindRhythm trial to assess LVO stroke diagnostic...

lvo stroke diagnosis mindrhythm
MindRhythm, a US medical technology company focused on preventing neurological injury in stroke, has announced the enrolment of the first patient in a multicentre...

Thrombolysis versus thrombectomy: Honours even between basilar occlusion treatments in CX...

basilar artery occlusion treatments
Thrombolysis is considered as effective as mechanical thrombectomy for the treatment of basilar artery occlusion (BAO)—despite existing evidence on both intervention options being limited....

Medtronic gains FDA approval to trial implantable tibial neuromodulation device

medtronic implantable tibial neuromodulation device
Medtronic has announced approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate its...